Five strains of adult mice were immunosuppressed with the synthetic glucocorticosteroid dexamethasone (DEX), administered either orally or intraperitoneally. The strains of mice used were C57BL/6N, DBA/2N, CBA, C3H/HeN, and BALB/cAnN. All mice were evaluated for susceptibility to Cryptosporidium parwum after intragastric inoculation with 106 oocysts per mouse. The DBA/2N, CBA, C3H/HeN, and BALB/cAnN mice given 0.25 ,ug of DEX per g per day orally (the dose and route previously used to infect rats with C. parvum) failed to develop chronic infections. However, the C57BL/6N mice sustained light infections during the entire 28-day experiment. The five strains of mice were also administered DEX intraperitoneally at concentrations ranging from 62.5 to 500 R,g/day. Only the C57BL/6N mice given DEX at 125 ,ug/day developed chronic infections which persisted over 10 weeks, suggesting that the genetic background of the mouse plays a role in determining susceptibility to cryptosporidiosis following immunosuppression with DEX. We believe that the C57BL/6N mouse model will prove to be superior to other animal models for evaluating potential anticryptosporidial agents, as well as for elucidating the immunological defects that allow C. parvum to establish chronic infections, because of cost effectiveness and ease in maintenance, breeding, and handling. We also evaluated the C3H/HeJ/beige mouse (lacks natural killer cell activity) and the C57BL/6N mouse maintained on a low-protein diet to induce immunosuppression. Neither of these mice exhibited heavy cryptosporidial infections.
Cryptosporidium parvum is a coccidian parasite that infects the microvillous region of epithelial cells lining the digestive and respiratory tracts of vertebrates (11, 22) . In immunocompetent hosts, C. parvum generally causes a short-term diarrheal illness that resolves spontaneously (7, 30) . However, in immunocompromised hosts, C. parvum may cause a life-threatening, prolonged, choleralike illness. No effective therapy for cryptosporidiosis is available, and the prognosis for immunocompromised patients, especially those with AIDS, is usually inauspicious (10) .
A suitable small animal model for chronic cryptosporidiosis is necessary to identify effective anticryptosporidial agents as well as to determine the immune abnormalities that allow persistent infections to develop. Immunocompetent laboratory animal models have been limited to neonatal mice (9, 24, 28) , neonatal rats (24) , and neonatal hamsters (16) . The disease has also been studied in infant primates (21, 22, 24) , fetal lambs (17) , piglets (1) , and calves (8, 11, 13, 24, 29) . Cryptosporidiosis has been reported in adult wild mice (18) and adult guinea pigs (6) . However, because of variations in the clinical presentation and patency of infection, determining the species of Cryptosporidium in guinea pigs remains controversial. The brevity of infection in all of these animal models does not allow sufficient time to suitably evaluate potential anticryptosporidial agents. As a result, a chronic-infection model for cryptosporidiosis would be extremely useful.
Chronic cryptosporidiosis has been reported for immunosuppressed rats (5, 26) and hamsters (27) , athymic mice (14, 31) , germfree adult mice (12) , T-cell subset-depleted severe combined immunodeficient (SCID) mice, and the National Institutes of Health (NIH) III (bglnu/xid) mice (20, 31 Earlier attempts to establish chronic infections in adult mice by the use of immunosuppressive therapy have failed (24, 28) . The aim of this study was to determine the susceptibility of five strains of mice immunosuppressed with the synthetic glucocorticosteroid dexamethasone (DEX), using various regimens of drug administration. The results revealed that C57BL/6N mice immunosuppressed by intraperitoneal injections of DEX at a dosage of 125 ,ug/day developed chronic cryptosporidiosis. The length and severity of the infections were determined by monitoring oocyst shedding intensities in fecal pellets and parasite colonization in mouse tissues. Parasites. The C. parvum oocysts (Iowa isolate) used in this study were originally obtained from Harley Moon (U.S. Department of Agriculture, Ames, Iowa). The oocysts were produced in experimentally infected Holstein calves and purified from feces by using discontinuous sucrose gradients (3). Purified oocysts were stored in 2.5% potassium dichromate at 4°C. Oocysts (stored for less than 4 months) used for inoculation were prepared by washing with RPMI 1640 base medium (Sigma Chemical Co.) to remove the potassium dichromate. Each mouse was inoculated intragastrically with 106 purified oocysts in a volume of 100 ,ul of RPMI 1640 base.
MATERIALS AND METHODS

Animals
Determination of docyst shedding in infected mice. Fecal pellets were collected from mice to monitor oocyst shedding throughout the experiment. Pellets were resuspended in a volume of 2.5% potassium dichromate approximately equal to twice that of the feces and stored at 4°C. Fecal suspensions were smeared onto microscope slides and observed for the presence of oocysts by an oocyst-specific monoclonal antibody-based direct immunofluorescence assay (4) . Smears were examined microscopically in a blind fashion and scored 0 to 4+ based on oocyst numbers. Scoring was as follows: 0, no oocysts detected; 1+, <5 oocysts per smear; 2+, 5 to 50 oocysts per smear; 3+, 50 to 100 oocysts per smear; and 4+, >100 oocysts per smear.
Histologic examination of tissues. Mice were necropsied at weekly intervals postinoculation (p.i.). Tissue samples harvested from the lungs, liver, gall bladder, pancreas, spleen, stomach, duodenum, jejunum, ileum, cecum, and large intestine were fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Stained sections were examined for C. parvum localization by using bright-field microscopy in a blind fashion and scored qualitatively according to parasite load. Because numbers of parasites widely distributed throughout the tissue (>50% of the tissue colonized). Statistical analysis. Treatment differences were statistically compared for significance at P < 0.01 utilizing analysis of variance (19) .
RESULTS
The results of the study designed to determine whether any of the five different strains of adult mice could be infected with C. parvum following immunosuppression with DEX are presented in Fig. 1 and 2 . Oocyst shedding intensities of mice given DEX orally at a dose of 0.25 ,ug/g/day are shown in Fig. 1 . All CBA mice died prior to inoculation with C. parvum. In the other four strains of mice, oocyst shedding was initially detected on day 6 p.i. Oocyst shedding was no longer detectable in the C3HIHeN and BALB/cAnN mice after 10 and 12 days p.i., respectively. Oocyst shedding also ceased in the DBA/2N mice after 21 days p.i. However, the C57BL/6N mice continued to shed oocysts throughout the duration of the 28-day experiment, even though shedding was particularly light in these mice after 14 days p.i.
Oocyst shedding intensities of mice given DEX intraperitoneally at a dose of 125 ,ug/day are shown in Fig. 2 After finding the susceptibility of the C57BL/6N mice given DEX intraperitoneally to C. parvum infections, we designed a study to determine the chronicity of C. parvum infections in C57BL/6N mice compared with nonimmunosuppressed mice. The results are presented in Fig. 3 . The intensities of oocyst shedding were significantly greater in the immunosuppressed than in the nonimmunosuppressed mice. Both groups of mice commenced oocyst shedding on day 4 p.i. The nonimmunosuppressed mice stopped shedding after day 7 p.i., whereas the group of immunosuppressed mice continued to shed oocysts throughout the 10-week experiment. There appeared to be a second, but lower, peak in mean oocyst shedding intensities on day 17 p.i. in the immunosuppressed mice. This may have been the result of autoinfection (8, 30) . Chronically infected mice exhibited soft (nondiarrhetic) stools, lethargy, and dehydration.
Microscopic examination of tissue sections revealed that C. parvum was localized predominantly in the small and large intestines of the DEX-immunosuppressed mice (Fig.  4) . Specifically, cryptosporidia were noted in the gastric glands of the stomach, duodenum, jejenum, ileum, and colon collected on day 60 p.i. The greatest levels of parasites were located in the jejenum, ileum, terminal ileum, and colon. The colonization levels increased toward the end of the experiment. No parasites were observed in the nonimmunosuppressed mice.
Three of the 10 C3H/HeJ/beige mice exhibited only mild oocyst shedding (1+) for 5 days and subsequently ceased to shed oocysts by day 6 p.i. No cryptosporidia were localized 
DISCUSSION
This study demonstrates the first successful attempt to produce chronic cryptosporidiosis in adult mice following drug-induced immunosuppression. The impetus for these experiments was the lack of both an in vitro culture system and a suitable adult small animal model to study the disease and evaluate potential anticryptosporidial agents. The most widely used laboratory animal model for research on C. parvum has been the neonatal mouse (2, 9, 23, 28) . Unfortunately, the small size and the short duration of the parasitic infection in the neonatal mouse (only 2 to 3 weeks) constitute significant disadvantages of this animal model. Attempts to develop germfree adult mice as a model for C. parvum have failed because of the low level of parasite colonization in the gut (12 
